Nav: Home

Restoring leg blood flow is better option than exercise for PAD patients

May 05, 2016

NASHVILLE, Tennessee, May 5, 2016 -- Restoring blood flow to the legs of patients with peripheral artery disease (PAD) may stop the progression of scarring in their leg muscles, according to preliminary research presented at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology / Peripheral Vascular Disease 2016 Scientific Sessions.

PAD causes pain and fatigue while walking due to poor blood circulation in arteries that supply blood to the limbs. The decreased blood flow can lead to substantial scarring and damage in leg muscles. Moreover, there are currently no available treatments once the scarring has occurred. Supervised exercise therapy and revascularization procedures (which reopen or bypass blockages in the blood vessels) may help PAD patients walk further and longer, but it is not known if these treatments affect the scarring process.

Researchers looked at levels of transforming growth factor-beta (TGF-β1) -- a protein that promotes scarring -- and the amount of collagen (tough protein fibers found in scars) in calf muscle biopsies from patients with PAD severe enough to be considered for surgery. Six months later, they compared changes in biopsy results among 20 patients who underwent revascularization, 19 who participated in a supervised exercise program, and 17 who had no treatment. Among the findings:
  • Scarring factors - collagen fibers and TGF-β1 - increased in the exercise and control groups, but not in the revascularization group;

  • Patients in both the revascularization and exercise groups increased their maximum walking time on treadmill, before calf pain made it impossible to continue;

  • Only patients in the revascularization group improved the distance they could walk in six minutes.

Neither exercise nor revascularization treatment reversed scarring that had already taken place in the calf muscles. However, "increasing blood flow to the leg with revascularization procedures halted the progression of scarring and allowed the patients to walk longer and further," said Duy Ha, B.S., lead author of the study and a doctoral candidate in cellular and integrative physiology at the University of Nebraska Medical Center in Omaha. "This suggests that the long-term benefits to the health of leg muscles is better with revascularization than with exercise therapy alone. Unfortunately, not all patients are candidates for these procedures, which carry significant risks, and the treated vessels may get blocked again,"

"We hope that we can develop therapies that directly decrease TGF-β1 and its associated scarring in the leg muscles of PAD patients. Such new treatments, when used alone or along with revascularization and exercise, may maintain or enhance the ability of our patients to walk and live healthy lives," Ha said.
-end-
Co-authors are George Casale, Ph.D.; Alicia Luis; Kevin Harkins; Reagan Huber; Tanmayee Changalasetty, Ruby Hickman; Mina Hanna, M.S.; Stanley Swanson, B.S.; Holly DeSpiegelaere, R.N.; and Iraklis Pipinos, M.D. Author disclosures are on the abstract.

This study is funded by the National Heart Lung and Blood Institute, National Institute of Aging, and the Charles and Mary Heider Fund for Excellence in Vascular Surgery. The V.A. Nebraska and Western Iowa Health Care System provided additional support.

Note: Meeting presentation time is 6 p.m. CT, Thursday, May 5th, 2016.

Additional Resources:

The American Heart Association's Peripheral Artery Disease site
Daily Science News from the ATVB meeting
Follow the news on @HeartNews Twitter #ATVBPVDScience and check out all the news and information across AHA/ASA social media on our Social Media Hub.

Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at http://www.heart.org/corporatefunding.

American Heart Association

Related Peripheral Artery Disease Articles:

Peripheral artery disease risk hinges on health factors and demographics, including race
The lifetime risk of lower-extremity peripheral artery disease (PAD), in which leg arteries narrow abnormally, is about 30 percent for black men and 28% for black women, with lower but still-substantial risks for Hispanics and whites, according to a study led by scientists at the Johns Hopkins Bloomberg School of Public Health.
Study quantifies smoking's strong link to peripheral artery disease
A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that cigarette smoking boosts the risk of peripheral artery disease, and this elevated risk can persist up to 30 years after smoking cessation.
Cigarette smoking associated with increased risk of peripheral artery disease in African-Americans
African-Americans who smoke cigarettes are more likely than those who don't to have peripheral artery disease (PAD).
Smoking linked to higher risk of peripheral artery disease in African-Americans
African-Americans who smoke appear to be at greater risk for peripheral artery disease, or PAD, new research has found.
Smokers with peripheral artery disease need more help to kick the habit
Study Highlight: While many people with peripheral artery disease smoke, few receive proven smoking cessation strategies from their doctor.
Scientists develop alternative treatment for peripheral artery disease
Cristina Sabliov, LSU Biological and Agricultural Engineering professor, and Tammy Dugas, professor in the LSU School of Veterinary Medicine's Department of Comparative Biomedical Sciences, have joined forces to fight peripheral artery disease, or PAD, an ailment affecting 8 million Americans.
Researchers look to worms for a new model of a peripheral nervous system disease
Scientists have discovered that a microscopic roundworm develops similar nerve damage to human patients when their muscle cells are genetically engineered to produce TTR proteins.
Stem cells show long-term success in treating severe peripheral arterial disease
A long-term study of patients who received stem cells to treat angiitis-induced critical limb ischemia (AICLI) shows the cells to be both safe and effective.
A wearable device intervention to increase exercise in peripheral artery disease
A home-based exercise program, consisting of wearables and telephone coaching, did not improve walking endurance for patients with peripheral artery disease, according to a study published in JAMA.
Effect of a home-based exercise program with wearable activity monitor, telephone coaching on walking endurance for peripheral artery disease
A home-based exercise program that consisted of a wearable activity monitor and telephone coaching to promote walking by patients with peripheral artery disease didn't improve walking endurance.
More Peripheral Artery Disease News and Peripheral Artery Disease Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.